Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancer

Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancer

Abstract Background Controversy exists regarding the optimal sequence of chemotherapy among women with operable node‐negative breast cancers with high‐risk tumor biology. We evaluated national patterns of neoadjuvant chemotherapy (NACT) use among women with early‐stage HER2+, triple‐negative (TNBC),...

Full description

Bibliographic Details
Main Authors:	Ipshita Prakash, N. Ben Neely, Samantha M. Thomas, Sarah Sammons, Rachel C. Blitzblau, Gayle A. DiLalla, Terry Hyslop, Carolyn S. Menendez, Jennifer K. Plichta, Laura H. Rosenberger, Oluwadamilola M. Fayanju, E. Shelley Hwang, Rachel A. Greenup
Format:	Article
Language:	English
Published:	Wiley 2022-02-01
Series:	Cancer Medicine
Subjects:	breast cancer cancer management clinical management neoadjuvant chemotherapy surgical oncology
Online Access:	https://doi.org/10.1002/cam4.4517

Similar Items

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
by: Nicole M. Melchior, et al.
Published: (2020-04-01)

Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study
by: Jie Yang, et al.
Published: (2024-04-01)

Neoadjuvant treatment for pancreatic cancer: Controversies and advances
by: Douglas Dias e Silva, et al.
Published: (2024-01-01)

History and current situation of neoadjuvant treatment for locally advanced esophageal cancer
by: Junyi Li, et al.
Published: (2021-09-01)

Neoadjuvant chemotherapy for colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis
by: Jiuzhou Chen, et al.
Published: (2022-08-01)

Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?
by: Nuttavut Sumransub, et al.
Published: (2021-09-01)

Lung Cancer Surgery after Neoadjuvant Immunotherapy
by: Dirk Stefani, et al.
Published: (2021-08-01)

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
by: Kamil D. Dalgatov, et al.
Published: (2021-08-01)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
by: Shouki Bazarbashi, et al.
Published: (2022-05-01)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
by: V F Semiglazov, et al.
Published: (2013-12-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
by: Anita De Rossi, et al.
Published: (2011-04-01)

Neoadjuvant Chemotherapy in Esophageal Cancer: Single Institution Experience
by: Shaffi Shaikh, et al.
Published: (2011-10-01)

Survival Outcomes of Patients with Locally Advanced Breast Cancer after Neoadjuvant Systemic Therapy in St. Luke’s Medical Center
by: Cristina G. Domingo, et al.
Published: (2023-05-01)

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
by: Hannah M. Knochelmann, et al.
Published: (2021-10-01)

Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues
by: Luigi Marano, et al.
Published: (2023-01-01)

Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01)

Does neoadjuvant rectal score predict treatment outcomes better than the all grading systems used in neoadjuvantly treated rectal cancer?
by: Fatma Sert, et al.
Published: (2023-10-01)

Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic Cancer
by: Brandon G. Smaglo
Published: (2023-04-01)

Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer
by: Takehiro Okabayashi, et al.
Published: (2022-11-01)

The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery
by: Mohammadtaghi Rajabi Mashhadi, et al.
Published: (2015-07-01)

Initial results of treatment of rectal cancer using the neoadjuvant treatment
by: Marić Zdravko, et al.
Published: (2014-01-01)

Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer
by: Madison L. Conces, et al.
Published: (2024-01-01)

Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
by: Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition)
Published: (2022-01-01)

Neoadjuvant systemic therapy for patients with gastric cancer: Current concepts and outcomes
by: Fatih Selcukbiricik, et al.
Published: (2016-01-01)

Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study
by: Yi‐min Han, et al.
Published: (2023-06-01)

Post-Neoadjuvant Treatment Strategies in Breast Cancer
by: Christiane Matuschek, et al.
Published: (2022-02-01)

Recent advance in neoadjuvant chemotherapy for rectal cancer
by: GUO Yang, GUO Tian′an, XU Ye
Published: (2022-07-01)

Neoadjuvant therapy for locally advanced rectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01)

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Kari T. Syvänen, et al.
Published: (2014-05-01)

A complex approach to continuous cardiac monitoring of neoadjuvant chemotherapy: Observational study
by: Yuri I. Buziashvili, et al.
Published: (2022-08-01)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
by: Jian Wang, et al.
Published: (2021-07-01)

A case of neoadjuvant chemotherapy‐resistant muscle‐invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy
by: Ichiro Yonese, et al.
Published: (2024-01-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Evaluation of Response and Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
by: Balaji Shewalkar, et al.
Published: (2023-07-01)

Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer
by: Xi Chen, et al.
Published: (2023-10-01)

Neoadjuvant chemotherapy for treatment patients with rectal cancer with adverse prognostic factors: A review
by: Aleksey A. Nevolskikh, et al.
Published: (2022-11-01)

A Narrative Review of Ultrasound Technologies for the Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
by: Wang J, et al.
Published: (2021-10-01)